Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease

Sandhoff disease (SD) is a progressive neurodegenerative lysosomal storage disorder characterized by GM2 ganglioside accumulation as a result of mutations in the <i>HEXB</i> gene, which encodes the β-subunit of the enzyme β-hexosaminidase. Lysosomal storage of GM2 triggers inflammation i...

Full description

Saved in:
Bibliographic Details
Main Authors: Nick Platt, Dawn Shepherd, David A. Smith, Claire Smith, Kerri-Lee Wallom, Raashid Luqmani, Grant C. Churchill, Antony Galione, Frances M. Platt
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/14/1/35
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841549292228050944
author Nick Platt
Dawn Shepherd
David A. Smith
Claire Smith
Kerri-Lee Wallom
Raashid Luqmani
Grant C. Churchill
Antony Galione
Frances M. Platt
author_facet Nick Platt
Dawn Shepherd
David A. Smith
Claire Smith
Kerri-Lee Wallom
Raashid Luqmani
Grant C. Churchill
Antony Galione
Frances M. Platt
author_sort Nick Platt
collection DOAJ
description Sandhoff disease (SD) is a progressive neurodegenerative lysosomal storage disorder characterized by GM2 ganglioside accumulation as a result of mutations in the <i>HEXB</i> gene, which encodes the β-subunit of the enzyme β-hexosaminidase. Lysosomal storage of GM2 triggers inflammation in the CNS and periphery. The NLRP3 inflammasome is an important coordinator of pro-inflammatory responses, and we have investigated its regulation in murine SD. The NLRP3 inflammasome requires two signals, lipopolysaccharide (LPS) and ATP, to prime and activate the complex, respectively, leading to IL-1β secretion. Peritoneal, but not bone-marrow-derived, macrophages from symptomatic SD mice, but not those from pre-symptomatic animals, secrete the cytokine following priming with LPS with no requirement for activation with ATP, suggesting that such NLRP3 deregulation is related to the extent of glycosphingolipid storage. Dysregulated production of IL-1β was dependent upon caspase activity but not cathepsin B. We investigated the role of IL-1β in SD pathology using two approaches: the creation of <i>hexb</i><sup>−/−</sup><i>Il1r1</i><sup>−/−</sup> double knockout mice or by treating <i>hexb</i><sup>−/−</sup> animals with anakinra, a recombinant form of the IL-1 receptor antagonist, IL-1Ra. Both resulted in modest but significant extensions in lifespan and improvement of neurological function. These data demonstrate that IL-1β actively participates in the disease process and provides proof-of-principle that blockade of the pro-inflammatory cytokine IL-1β may provide benefits to patients.
format Article
id doaj-art-aa38bb2487e340e281ca9ed30ffe6111
institution Kabale University
issn 2073-4409
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj-art-aa38bb2487e340e281ca9ed30ffe61112025-01-10T13:16:19ZengMDPI AGCells2073-44092025-01-011413510.3390/cells14010035Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff DiseaseNick Platt0Dawn Shepherd1David A. Smith2Claire Smith3Kerri-Lee Wallom4Raashid Luqmani5Grant C. Churchill6Antony Galione7Frances M. Platt8Department of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UKDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UKDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UKDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UKDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UKNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Windmill Road, Oxford OX3 7LD, UKDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UKDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UKDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford OX1 3QT, UKSandhoff disease (SD) is a progressive neurodegenerative lysosomal storage disorder characterized by GM2 ganglioside accumulation as a result of mutations in the <i>HEXB</i> gene, which encodes the β-subunit of the enzyme β-hexosaminidase. Lysosomal storage of GM2 triggers inflammation in the CNS and periphery. The NLRP3 inflammasome is an important coordinator of pro-inflammatory responses, and we have investigated its regulation in murine SD. The NLRP3 inflammasome requires two signals, lipopolysaccharide (LPS) and ATP, to prime and activate the complex, respectively, leading to IL-1β secretion. Peritoneal, but not bone-marrow-derived, macrophages from symptomatic SD mice, but not those from pre-symptomatic animals, secrete the cytokine following priming with LPS with no requirement for activation with ATP, suggesting that such NLRP3 deregulation is related to the extent of glycosphingolipid storage. Dysregulated production of IL-1β was dependent upon caspase activity but not cathepsin B. We investigated the role of IL-1β in SD pathology using two approaches: the creation of <i>hexb</i><sup>−/−</sup><i>Il1r1</i><sup>−/−</sup> double knockout mice or by treating <i>hexb</i><sup>−/−</sup> animals with anakinra, a recombinant form of the IL-1 receptor antagonist, IL-1Ra. Both resulted in modest but significant extensions in lifespan and improvement of neurological function. These data demonstrate that IL-1β actively participates in the disease process and provides proof-of-principle that blockade of the pro-inflammatory cytokine IL-1β may provide benefits to patients.https://www.mdpi.com/2073-4409/14/1/35Sandhoff diseaseGM2 gangliosidosislysosomal storage diseaseNLRP3 inflammasomeIL-1βinflammation
spellingShingle Nick Platt
Dawn Shepherd
David A. Smith
Claire Smith
Kerri-Lee Wallom
Raashid Luqmani
Grant C. Churchill
Antony Galione
Frances M. Platt
Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease
Cells
Sandhoff disease
GM2 gangliosidosis
lysosomal storage disease
NLRP3 inflammasome
IL-1β
inflammation
title Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease
title_full Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease
title_fullStr Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease
title_full_unstemmed Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease
title_short Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease
title_sort dysregulation of the nlrp3 inflammasome and promotion of disease by il 1β in a murine model of sandhoff disease
topic Sandhoff disease
GM2 gangliosidosis
lysosomal storage disease
NLRP3 inflammasome
IL-1β
inflammation
url https://www.mdpi.com/2073-4409/14/1/35
work_keys_str_mv AT nickplatt dysregulationofthenlrp3inflammasomeandpromotionofdiseasebyil1binamurinemodelofsandhoffdisease
AT dawnshepherd dysregulationofthenlrp3inflammasomeandpromotionofdiseasebyil1binamurinemodelofsandhoffdisease
AT davidasmith dysregulationofthenlrp3inflammasomeandpromotionofdiseasebyil1binamurinemodelofsandhoffdisease
AT clairesmith dysregulationofthenlrp3inflammasomeandpromotionofdiseasebyil1binamurinemodelofsandhoffdisease
AT kerrileewallom dysregulationofthenlrp3inflammasomeandpromotionofdiseasebyil1binamurinemodelofsandhoffdisease
AT raashidluqmani dysregulationofthenlrp3inflammasomeandpromotionofdiseasebyil1binamurinemodelofsandhoffdisease
AT grantcchurchill dysregulationofthenlrp3inflammasomeandpromotionofdiseasebyil1binamurinemodelofsandhoffdisease
AT antonygalione dysregulationofthenlrp3inflammasomeandpromotionofdiseasebyil1binamurinemodelofsandhoffdisease
AT francesmplatt dysregulationofthenlrp3inflammasomeandpromotionofdiseasebyil1binamurinemodelofsandhoffdisease